Celcuity, Inc. (CELC)
106.96
+1.68
(+1.60%)
USD |
NASDAQ |
Jan 16, 16:00
107.08
+0.12
(+0.11%)
After-Hours: 20:00
Celcuity SG&A Expense (TTM): 18.59M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Olema Pharmaceuticals, Inc. | 18.61M |
| Replimune Group, Inc. | 102.36M |
| Arrowhead Pharmaceuticals, Inc. | 123.94M |
| Cidara Therapeutics, Inc. | 28.09M |
| Cogent Biosciences, Inc. | 51.34M |